Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

No supporting evidence regarding Tamiflu and Relenza

There is no evidence to support claims that Tamiflu and Relenza, two flu medications, reduce hospital admissions or complications related to flu, according to research.  

There is no evidence to support claims that Tamiflu and Relenza, two flu medications, reduce hospital admissions or complications related to flu, according to research.  Roche’s Tamiflu (oseltamivir) and GlaxoSmithKline’s Relenza (zanamivir) are two drugs normally prescribed for the prevention and treatment of flu in adults and children, preventing further complications and admissions to hospital. But researchers claim there is no substantial evidence to make these claims.  The new study, jointly published by The Cochrane Collaboration and The BMJ, said that when used as a preventative treatment, the drug can reduce the risk of people suffering symptomatic influenza, but it

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy